Carbon dots, the
nanostructures of carbon, have excellent optical
and chemical properties and find a range of applications in various
fields of biology and medicine. In the current study, carbon dots
are synthesized using in vitro nonenzymatic glycosylation
at 37 °C, which is the conventional method for the synthesis
of Advanced Glycosylation End products. While comparing the physicochemical
properties using a series of physical and chemical analyses including
light absorption, fluorescence, photoluminescence, chemical composition,
functional group analysis, and in vitro imaging,
striking similarities are found among Carbon dots and Advanced Glycosylation
End products. Based on the evident resemblance between the two, we
propose either the presence of a common structural backbone or the
coexistence of the two individual chemical entities. Thus, the formation
of carbon dots at physiological temperatures raises health concerns
as nonenzymatic glycosylation is a physiological process in humans
and the rate of which is elevated during diabetes. The Advanced Glycosylation
End products are known to have a detrimental effect in diabetic patients,
and the chemical similarity between the two questions the widely studied
biocompatibility of carbon dots.